Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefitinib plus Anastrozole in Metastatic Breast Cancer
NCT00077025Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jan 2004
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of gefitinib in breast cancer, sponsored by AstraZeneca. Started Jan 2004; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00077025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00077025.